登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Activin RIIB】

Activin RIIB信息

英文名称:Activin receptor type-2B
中文名称:激活素受体-2B
靶点别称:EC:2.7.11.30,EC 2.7.11,Activin receptor type IIB,ACVR2B,Activin A Receptor Type 2B,Activin A Receptor, Type IIB,Activin Receptor Type-2B,EC 2.7.11.30,ActR-IIB,ACTRIIB,HTX4
上市药物数量:0
临床药物数量:2
最高研发阶段:临床二期

Licensing 项目合作

项目名称 药物类型 治疗领域 适应症 阶段 权益地区
ActRIIB抑制剂 小分子 肿瘤学,癌症,代谢性疾病 肿瘤恶液质 临床前 全球

Activin RIIB产品列表

ACRO质量管理体系
 
评论(0)
 

Activin RIIB分子别名

ACVR2B,ACTRIIB,MGC116908

Activin RIIB分子背景

Activin receptor type-2B (ACVR2B) is also known as ActR-IIB and MGC116908, ACVR2B is an activin type 2 receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. Defects in ACVR2B are the cause of visceral heterotaxy autosomal type 4 (HTX4).

Activin RIIB临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Bimagrumab BYM-338; LY-3985863 临床二期 Morphosys Ag, 诺华制药 二型糖尿病, 包涵体肌炎, 肥胖症, 慢性阻塞性肺疾病, 肌肉减少症 详情
BIIB-110 BIIB-110; BIIB110; ALG-801 临床一期 Alivegen USA Inc 肌病, 脊髓性肌萎缩 详情
LAE-123 LAE-123 详情

消息提示

请输入您的联系方式,再点击提交!

确定